There is provided a method of reducing insulin resistance in a mammalian patient comprising selecting a patient suffering from insulin resistance and administering a compound which increases hepatic glutathione and a compound which increases hepatic nitric oxide.

 
Web www.patentalert.com

< Methods of controlling hydrogen fluoride pressure during chemical fabrication processes

> Rapid activation catalyst system in a non-thermal plasma catalytic reactor

> Method for separating uranium (VI) from actinides(IV) and/or actinides (VI) and its uses
~ 00561